Beyond the “Jewish panel”: the importance of offering expanded carrier screening to the Ashkenazi Jewish population

[1]  D. Huster.  [Wilson disease]. , 2020, Der Internist.

[2]  S. Tsang,et al.  Stargardt Disease. , 2020, Advances in experimental medicine and biology.

[3]  K. Goddard,et al.  The evolving landscape of expanded carrier screening: challenges and opportunities , 2018, Genetics in Medicine.

[4]  Kyle A. Beauchamp,et al.  Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen , 2018, Genetics in Medicine.

[5]  W. H. Pearse,et al.  American College of Obstetricians and Gynecologists , 2018, Definitions.

[6]  I. Haque,et al.  Smith–Lemli–Opitz syndrome carrier frequency and estimates of in utero mortality rates† , 2017, Prenatal diagnosis.

[7]  Committee Opinion No. 691: Carrier Screening for Genetic Conditions. , 2017, Obstetrics and gynecology.

[8]  A. V. van Kuilenburg,et al.  Dihydropyrimidine Dehydrogenase Deficiency: Metabolic Disease or Biochemical Phenotype? , 2017, JIMD reports.

[9]  Ruofan Yao,et al.  Genetic Carrier Screening in the Twenty-first Century. , 2016, Clinics in laboratory medicine.

[10]  H. Kayserili,et al.  Responsible implementation of expanded carrier screening , 2016, European Journal of Human Genetics.

[11]  Jason M Franasiak,et al.  Expanded carrier screening in an infertile population: how often is clinical decision making affected? , 2016, Genetics in Medicine.

[12]  Judy H. Cho,et al.  Expanded genetic screening panel for the Ashkenazi Jewish population , 2015, Genetics in Medicine.

[13]  T. Bird,et al.  PMM2-CDG (CDG-Ia) -- GeneReviews(®) , 2016 .

[14]  Susan Sparks,et al.  PMM2-CDG (CDG-Ia) , 2015 .

[15]  Shivani Nazareth,et al.  Changing trends in carrier screening for genetic disease in the United States , 2015, Prenatal diagnosis.

[16]  Mary E Norton,et al.  Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Feta , 2015, Obstetrics and gynecology.

[17]  C. Pu,et al.  Clinical and pathological features of patients with nemaline myopathy. , 2014, Molecular medicine reports.

[18]  M. Birlik,et al.  Familial Mediterranean fever: An updated review. , 2014, European journal of rheumatology.

[19]  Balaji S. Srinivasan,et al.  An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals , 2012, Genetics in Medicine.

[20]  M. Nowaczyk,et al.  Smith–Lemli–Opitz syndrome: Phenotype, natural history, and epidemiology , 2012, American journal of medical genetics. Part C, Seminars in medical genetics.

[21]  C. Woods,et al.  Congenital disorders of glycosylation. , 2012, Advances in neonatal care : official journal of the National Association of Neonatal Nurses.

[22]  R. Finkel,et al.  Spinal muscular atrophy , 2011, Nature Reviews Disease Primers.

[23]  M. Berndt,et al.  Bernard-Soulier syndrome , 1998, Haematologica.

[24]  Minjie Luo,et al.  Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases , 2010, Human mutation.

[25]  Matthew J. Nichols,et al.  Lack of genotype-phenotype correlations and outcome in MCAD deficiency diagnosed by newborn screening in New York State. , 2010, Molecular genetics and metabolism.

[26]  T. Scholl,et al.  Differences in SMN1 allele frequencies among ethnic groups within North America , 2009, Journal of Medical Genetics.

[27]  S. Duga,et al.  Factor XI Deficiency , 2009, Seminars in thrombosis and hemostasis.

[28]  Weimin Sun,et al.  Prevalence of known mutations in the familial Mediterranean fever gene (MEFV) in various carrier screening populations , 2008, Genetics in Medicine.

[29]  B. Pletcher,et al.  Carrier screening in individuals of Ashkenazi Jewish descent , 2008, Genetics in Medicine.

[30]  Michael M. Kaback,et al.  Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model , 2000, European Journal of Pediatrics.

[31]  H. Sarnat.  New Insights Into the Pathogenesis of Congenital Myopathies , 1994, Journal of child neurology.